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Background: Most projections of type 2 diabetes (T2D) prevalence are simply based on demographic change
(i.e. ageing). We developed a model to predict future trends in T2D prevalence in Tunisia, explicitly taking into
account trends in major risk factors (obesity and smoking). This could improve assessment of policy options for
prevention and health service planning.
Methods: The IMPACT T2D model uses a Markov approach to integrate population, obesity and smoking
trends to estimate future T2D prevalence. We developed a model for the Tunisian population from 1997 to
2027, and validated the model outputs by comparing with a subsequent T2D prevalence survey conducted in
2005.
Results: The model estimated that the prevalence of T2D among Tunisians aged over 25 years was 12.0% in
1997 (95% confidence intervals 9.6%–14.4%), increasing to 15.1% (12.5%–17.4%) in 2005. Between 1997 and
2005, observed prevalence in men increased from 13.5% to 16.1% and in women from 12.9% to 14.1%. The
model forecast for a dramatic rise in prevalence by 2027 (26.6% overall, 28.6% in men and 24.7% in women).
However, if obesity prevalence declined by 20% in the 10 years from 2013, and if smoking decreased by 20%
over 10 years from 2009, a 3.3% reduction in T2D prevalence could be achieved in 2027 (2.5% in men and 4.1%
in women).
Conclusions: This innovative model provides a reasonably close estimate of T2D prevalence for Tunisia over
the 1997–2027 period. Diabetes burden is now a significant public health challenge. Our model predicts that
this burden will increase significantly in the next two decades. Tackling obesity, smoking and other T2D risk
factors thus needs urgent action. Tunisian decision makers have therefore defined two strategies: obesity
reduction and tobacco control. Responses will be evaluated in future population surveys.
Keywords: Type 2 diabetes prevalence, Demographic changes, Obesity trends, Smoking trends, Projection,
Target strategies, Modeling, TunisiaBackground
The burden of Non-Communicable Diseases (NCDs),
including diabetes and cardiovascular diseases (CVDs),
represents a real challenge to health systems. The Eastern
Mediterranean Region (EMR) has been recognized as a
hotspot for CVDs and type 2 diabetes (T2D). About 47%
of the region’s current burden of disease is considered to
be due to NCDs, and this may rise to about 60% by the* Correspondence: habibabr@yahoo.fr
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project [1].
Diabetes contributes substantially to this burden. The
most recent estimates of the burden of diabetes are
alarming, suggesting that in 2013 there were 382 million
people with diabetes worldwide [2]. Whilst there have
been changes in the incidence of type 1 diabetes, it is
type 2 diabetes that is largely responsible for the global
epidemic of diabetes [3]. Moreover, increasing preva-
lence of the key risk factors for T2D will also contribute
to the urgency of the problem in many parts of the
world.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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syndrome, are the most important risk factors for diabetes
[4-6]. Rising rapidly across the world, obesity is now re-
placing more traditional problems such as malnutrition in
developing countries [7]. There is also an extensive body
of literature reporting on the association between the inci-
dence of diabetes and active smoking, the leading cause of
avoidable death and a prevalent risk factor globally [8-12].
Estimates of the current and future burden of T2D are
important in order to allocate community and health
resources, and to emphasize the role of life style, and
encourage measures to counteract trends for increasing
prevalence [13]. In a context of developing countries, such
projections are characterized by their scarcity and lack
of accuracy: most estimates e.g. those produced by the
International Diabetes Federation Diabetes Atlas are
based on trends in urbanisation and demographic changes.
It seems plausible that predictions based on trends in key
risk factors, would be more realistic.
To gain insight on T2D prediction and prevention in
Tunisia, we adopted a newly developed tool, the T2D
(IMPACT) model, this model was designed for use in
settings where available T2D risk factor data might be
limited (particularly low and middle income countries),
though it was originally developed and validated using
data from England and Wales [14].
Recently, the model has been further developed and
validated in developing countries such as Saudi Arabia,
Palestine, Syria and Turkey [15-19].
This study populates the T2D-IMPACT model with
Tunisian data, describes trends in T2D and key risk factors,
and uses the model to predict likely future prevalence of
T2D according to demographic changes and trends in
major risk factors; obesity and smoking. Finally, it uses theFigure 1 The type 2 diabetes model structure.model to estimate the likely future impact of different
policy scenarios such as policies to improve tobacco
control, or reduce obesity.Methods
Model structure
The total population is divided in several pools: T2D,
obese, smoker and “healthy” (i.e.: non obese, non-smokers,
no diabetes). A proportion of the population in each pool
moves through pathways to other states as described in
Figure 1. Population demographic trends are used to in-
form the relative size of the “starting states”, and transition
probabilities are used to estimate the proportion of
persons moving from the starting states to the T2D
and death states. There are two “absorbing states”: T2D
related death and non-T2D related deaths as competing
risks for mortality.
Potential overlaps between the healthy, obese and smok-
ing group are managed estimated by calculating the condi-
tional probabilities of membership which allows estimating
what proportion of diabetic new cases can be attributed to
smoking and obesity at each cycle. These conditional prob-
abilities were obtained from the initial population-based
cross sectional survey [16-19].
The model requires a starting T2D prevalence estimate
for a given year; in addition to population estimates, and
obesity and smoking trends over a time period of interest
(all stratified by age group and sex).
A key element of the model is the calculation of the
transition probabilities, particularly those related to T2D
incidence. For estimating T2D incidence we first estimated
a population incidence for T2D based on DM prevalence,
population total mortality and T2D relative mortality
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[20,21]. T2D relative mortality is calculated using an
approach proposed by Barendregt et al. [22,23]. Details
of these procedures are available in the Additional file 1.
We developed the model for the Tunisian population
aged over 25 years old, for the time period between 1997
and 2027. The data sources for this study include the
National Institute of Statistic for annual demographic pro-
jections and mortality data [24,25]. Census data are based
on the 1994 and 2004 census and include projections of
the 2027 population.
The prevalence of T2D in the starting year (1997) was
obtained from the Tunisian National Nutrition Survey
1996/97 [26,27]. This survey included a representative
sample of 3635 adults over 20 years old. T2D cases
were defined as people with measured fasting plasma
glucose ≥7 mmol/l or having a previous diagnosis of T2D.
To estimate smoking prevalence in 1997, we used a sur-
vey conducted by the National Institute of Public Health
in 1996/1997 [28]. This included a representative national
sample of 5696 subjects aged 25 and over
For the obesity prevalence in 1997, we used data from
the Tunisian National Nutrition Survey 1996/97 [27].
Data in 2005 was obtained from the survey of Transition
Epidemiological and Health Impact in the North Africa
project (TAHINA), based on a nationally representative
sample of 8007 adults aged 35–75 years old. Assumptions
were made for the groups aged 25–34 and 75 years and
over where prevalence data was not available in 2005 [29]
(Table 1).Table 1 Data sources
Parameters Sources
Population data • National Institute of Statistics in Tunisia
Mortality data
Mortality Causes • National Public Health Institute
Total Mortality • National Institute of Statistics in Tunisia
[24,25]
Diabetes • Tunisian National Nutrition Survey
1996/97
• Cardiovascular Epidemiology and
Prevention Research Laboratory
Obesity • Tunisian National Nutrition Survey
1996/97
• Cardiovascular Epidemiology and
Prevention Research Laboratory
Smoking • National Institute of Public Health in
1996/1997
• Cardiovascular Epidemiology and
Prevention Research Laboratory
Relative risk mortality
calculation
Verona Study
Incidence calculation DISMODThe observed prevalence was presented as prevalence
(95% confidence intervals).
Model validation
Model Validation is an important aspect of any modeling
exercise, frequently overlooked. We developed a model
for Tunisia, over the period 1997 to 2027, based on preva-
lence data in 1997. One subsequent survey (TAHINA, de-
scribed above) with data on T2D prevalence was conducted
in 2005, and we therefore compared the model outputs
with the observed prevalence estimates for this year [29].
T2D cases in the 2005 survey were defined as people with
measured fasting capillary glucose ≥ 6.1 mmol/l or having a
previous diagnosis of T2D. For youngest (25–34) and oldest
(≥75) age groups (where data was not available from
TAHINA), we assumed that the risk factor profile was
similar to the adjacent age group [29]. We assumed
that fasting plasma glucose ≥7 mmol/l is equivalent to
capillary fasting glucose of ≥6.1 mmol/l. This equiva-
lence has recent been demonstrated using Tunisian
data [30].
Type 2 diabetes forecast and policy scenarios
First, we present forecasts for T2D prevalence and the
burden up to 2027 (30 years from our initial prevalence
estimate in 1997) assuming that current trends in obes-
ity and smoking continue. Obesity trends were capped
to avoid implausibly high obesity trends, based on evidence
of “leveling off” of obesity which has now been reported in
several populations [31,32]. Then, we explored the poten-
tial effect of population level interventions to reduce smok-
ing and obesity.
A smoking target was set by the Ministry of Health in
2009 [33]. The smoking strategy is composed of education,
sensitization, legislation, tariff policy and coordination
with stakeholders to reduce the prevalence of smoking
by 20% in 10 years. An obesity target was set by the Na-
tional Institute of Nutrition in 2010 [34]. The obesity
strategy is focused on encouraging the consumption of
healthy foods, development of sports activities, dissem-
ination of the information about the importance of healthy
nutrition and lifestyle, and early detection of obesity. The
target is to reduce the prevalence by 20% in 5 years.
However this target appears unachievable so in the model
we assumed that the strategy could reduce obesity by 20%
over 10 years.
Sensitivity analysis
We used the analysis of the extremes method [35] con-
sisting of running the model with all parameters set to
minimum and maximum realistic values. This is a very
conservative approach, but allows a more transparent
understanding of the effect of each parameter on uncer-
tainty in model estimates.
Saidi et al. BMC Public Health  (2015) 15:104 Page 4 of 8Results
Demographic and epidemiological changes
Table 2 presents demographic and epidemiological changes
in Tunisia in 1997 and 2005.
Demographic changes
Tunisia has about 10 million inhabitants. We considered
the population aged over than 25 years. For this age group,
the number of men is estimated to grow from 2125
thousand in 1997 to 3879 thousand in 2027 and from
2175 to 4117 thousand for women. The proportion of
young people aged 25–34 years will decrease from 34.5%
in 1997 to 22.9% in 2027. By 2027, 16% of the population
25 years and above will be aged over 65 compared with
13% in 1997.
Observed prevalence of type 2 diabetes
The observed prevalence of T2D in Tunisia in 1997 was
overall 13.1% (confidence interval (CI):11.9-14.3); 13.5%
(CI: 11.5–15.4) in men and 12.9% (CI: 11.4–14.3) in
women, with a clear tendency to increase with age, ex-
cept for men aged between 65 and 74 years.
Obesity and smoking trends
Obesity prevalence rose from 7.9% in 1997 to 13.0% in
2005 in men (annual increase of 8%) and from 25.9% to
29.9% in women (annual increase 2%). Based on our as-
sumptions, obesity prevalence would increase to 27.0%
in men and 44.0% in women by 2027.
The annual smoking trends showed a decrease in men
(−1%) (from 48% to 45%), but an increase in women. The
annual percentage increase among women was 9% (from
1.5% to 2.5% respectively between 1997 to 2005). The
projected prevalence for 2027 is 47.2% in men and 7.8%
in women.Table 2 Tunisian population aged 25 years and above, obesit
groups in 1997 and 2005
1997
Age groups Population N
(Thousand)
Diabetes mellitus
type II (%)
Smoking (%) Obesity
M* W** M W M W M W
25-34 733 751 8.0 6.8 58.8 0.9 4.9 1
35-44 549 546 8.6 8.6 49.7 1.9 11.3 2
45-54 318 329 15.6 13.6 43.4 2.0 8.3 3
55-64 261 264 18.4 21.0 33.4 2.0 7.4 3
65-74 174 201 15.3 22.2 33.4 1.4 8.2 2
75+ 90 85 23.5 26.4 33.6 0.9 10.0 1
Total 2125 2175 13.5 12.9 48.0 1.5 7.9 2
*M: Men.
**W: Women.
N: Number.Type 2 diabetes p
Assuming these annual trends in risk factors continue,
the forecast prevalence of T2D for 2027 is overall 26.6%
(min 22.8 –max 29.6): 28.6% in men (min 24.6 –max 31.6)
and 24.7% in women (min 21.2 –max 27.8) (Figure 2,
Table 3). The total number of Tunisian people with T2D is
projected to rise from 516 thousands in 1997 to 2125
thousands in 2027, an increase of 300%. This huge rise of
the T2D prevalence is mainly due to the increase of young
people aged 25–54 years with T2D.
Scenario projections
If the national strategies on tobacco and obesity control
achieve their objectives a 3.3% (min 2.1- max 4.6) reduc-
tion in T2D prevalence would be achieved by 2027; 2.5%
(min 1.5-max 3.9) in men and 4.1% (min 2.7–5.6 max in
women) (Table 3), this corresponds to 266,691 (min
135,040- max 458,418) fewer persons with T2D (98,479
fewer men and 168,223 fewer women). Detailed results
with sensitivity analysis are shown in Table 3.
Validation
For validation, comparisons of the model estimates showed
a close fit with the observed prevalence of T2D in Tunisia
in the TAHINA survey in 2005 (the only point available for
validation): the model prevalence estimate was 15.1% over-
all (observed 15.2%), 16.2% (16.1%) in men and 14.0%
(14.1%) in women. The modeled and observed estimates
of T2D prevalence are shown in Figure 3.
Discussion
The forecast prevalence of T2D for 2027 is 26.6% overall
(28.6% in men and 24.7% in women) with a 300% in-
crease in the number of persons with T2D between 1997
and 2027. Two initiatives for primary prevention of obes-
ity and smoking have been proposed. If these strategiesy and smoking prevalence trends by gender and age
2005
(%) Population N
(Thousand)
Diabetes mellitus
type II (%)
Smoking (%) Obesity (%)
M W M W M W M W
7.3 798 849 13.9 9.2 50.0 6.8 7.3 17.3
8.8 671 706 15.9 11.8 53.8 2.6 14.4 33.7
8.8 522 516 17.2 14.8 47.0 2.0 20.4 45.5
2.5 282 299 22.6 21.9 42.4 2.0 17.0 35.2
5.9 226 225 16.9 21.3 26.2 2.2 10.4 28.1
5.7 126 119 18.7 16.8 18.8 1.4 10.0 19.9
6.0 2625 2713 16.1 14.1 45.0 2.5 13.1 29.9
Figure 2 Estimated prevalence of type 2 diabetes.
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prevalence could be achieved by 2027 (2.5% in men and
4.1% in women) and will result in 13% fewer people with
T2D by 2027.
These T2D projections are somewhat higher then predic-
tions made for developing countries by the International
Diabetes Federation (IDF) in 2011 for the year 2030 [36].
The likeliest explanation for this difference is that the IDF
projections were based only on demographic changes and
urbanization, ignoring changes in population risk factor
profiles, other than what may be implicit via urbanization.
In fact, recent trends in T2D risk factors rates and major
advances in the understanding of the natural history of
T2D have not been formally incorporated into prior fore-
casts of the burden of T2D for the Tunisian population.
In developing our forecasting model, we model two
dynamic processes to estimate the T2D population. First,
new people are diagnosed and added to the T2D popula-
tion. Second, other individuals with existing T2D die and
leave this sub-population. With the balance of these two
processes, the prevalence of T2D in the total population
changes on an annual basis, depending on factors such as
the rate of obesity, active smoking and age of those at risk.
The model provides a rigorous assessment of the future
burden of T2D that accounts for both the natural history
of the disease and demographic changes. More import-
antly, the model can also be used to provide estimates of
the impact of alternative policy strategies tackling obesity
and smoking. The current obesity trends, when projected
into the future result in substantial increases in this mainTable 3 Scenario projection rate of prevalence of type 2
diabetes (T2D) by gender with sensitivity analysis
(Minimum-Maximum)
Men (%) Women (%) Total (%)
2015 22.3 (18.7-25.0) 17.0 (14.7-19.2) 19.6 (16.6-22.0)
2020 24.1 (20.6-26.6) 18.6 (16.2-20.6) 21.3 (18.4-23.5)
2027 26.1 (23.0-27.7) 20.6 (18.6-22.2) 23.2 (20.7-24.9)
The type 2 diabetes model structure.determinant of T2D. The rate of increase is more pro-
nounced among men (annual increase of 6% versus 2% in
women). Similarly, smoking rates remain high among men
and are lower but increasing in women. If these rates con-
tinue to 2027 nearly half of all men and 8% of women will
be current smokers.
Obesity is a global epidemic, and rates are particularly
high in the Middle East (38–44%) compared with 21% in
USA and 23% in Canada [37]. In developing countries
such as Palestine diabetes mellitus prevalence estimated
by the model forecasts were 20.8% for 2020 and 23.4% for
2030 [17]. A recent study in Saudi Arabia was published
to validate the Markov model, this found that prevalence
estimates from this new Markov model were consistent
with the 2005 national survey and very similar to the
Global Burden of Diseases (GBD) study [16].
In Tunisia, adding urgency to the T2D debate is the
finding that the number and proportion of obese people
is dramatically increasing. Our model predicts that 21.1%
of men and 40.5% of women will be obese in 2027, in-
creasing from 6.8% and 22.6% respectively at the time of
the 1997 nutritional survey [36]. Whilst these predicted
obesity prevalence estimates may seem very high, they are
in line with the alarming findings of a more recent survey
conducted in 2005 in the great Tunis area (the capital of
Tunisia). Whilst obesity is more common in urban areas
[26] this survey estimated that 34% of adults (and 46% of
women were obese) [38].
Recent studies among adolescents have shown similar
dramatic increases. Skhiri et al. found that overweight
had increased markedly among those aged 15 to 19 years
from 2.9% in 1997 to 17.4% in 2005 for boys and from
13.5% to 20.7% for girls for the same period. Furthermore,
abdominal obesity appeared as a significant feature in
most overweight adolescents. These findings are very
alarming since these adolescents are at high risk of de-
veloping later chronic diseases [39].
Smoking is also globally recognized as the most serious
public health problem. As predicted by the model, female
Figure 3 Comparison of model and observed estimates for type 2 diabetes prevalence by gender: Tunisia 1997 and 2005.
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survey 2005) to 7.8% by 2027. Although tobacco con-
sumption seems to have fallen slightly in men during these
last 20 years, it is still at a very high level and the conse-
quences of this tobacco use in term of mortality will be
considerable [40]. We estimate that 47.2% of men will
smoke in 2027 increasing from 45.8% in 2005. Comprehen-
sive tobacco control policies including multiple and coordi-
nated actions to prevent the uptake of smoking in young
people, and help smokers stop smoking are urgently needed.
Limitations of the study
The modeling approach used in the study synthesized
the key risk factors to help predict T2D prevalence in
the future. It also provided estimates of the impact of
alternative policy scenarios. Additionally, the model
assessed the potential maximum and minimum plaus-
ible effects of these factors using rigorous sensitivity
analyses which examined systematically the influence of
uncertainties in the assumptions used in the studies.
This modeling approach also has obvious limitations.
The model assumes “non-reversibility”: individuals can-
not move from “healthy” to obese and back to “healthy”
again, or from smoker and back to “healthy” or the like.
This could theoretically overestimate obesity and smoking,
and thus T2D prevalence. However, in Tunisia available
evidence suggests that very few smokers have ever quit
and that people who are overweight or obese rarely be-
come a healthy weight again. Thus, this limitation may
not be significant in this population [28]. The model
was also based on many assumptions that are reasonable
but still uncertain. The underlying assumption in these es-
timates is that a person with T2D of a particular age will
have the same risk of dying in 2027, as they did in 1991
(date of the VERONA study) [23].and a person who is
obese or a smoker will have the same risk of developing
T2D in 2027, as he or she had 20 years previously. Never-
theless, since most studies indicate rising risk and de-
creasing mortality over time, these estimates are likely
to be conservative. Furthermore, an important assump-
tion is that this method requires a population in equi-
librium, since the consistency between epidemiologicalestimates depends on the underlying trends in each
parameter. However it is difficult to disentangle these
effects from data inaccuracy. The robustness of the ap-
proach to violations of these assumptions is not known.
We estimated diabetes incidence using a previously pub-
lished and validated tool (DISMOD2) but it is notoriously
difficult to assess the accuracy of these estimates, given
the limitations (reversibility and changes in dynamic
equilibrium) mentioned above.
Moreover, a large number of factors that increase T2D
risk were not considered in our model, such as body fat
distribution, duration of obesity, weight gain, physical ac-
tivity, diet, the in utero environment, infant feeding prac-
tices, childhood stunting and genetic factors [41].
For smoking, the lack of adjustment for socioeconomic
status in the meta-analysis (only 6 studies adjusted for
socioeconomic status or education), diet (only 2 studies),
physical activity (only 13 studies), and alcohol consump-
tion (only 14 studies) could inflate the association between
smoking and T2D.
Data used were obtained from various surveys, meth-
odologies and sampling strategies as detailed in the
Additional file 1. The demographic information was ob-
tained from the census data and the risk factor trends
were obtained from well-designed epidemiological stud-
ies and surveys using the WHO STEPS methodology.
Finally, certain assumptions were needed to fill in the
gaps for missing information. Assumptions were thus made
for the groups aged 25–34 and 75 years and over where
prevalence data was not available. These assumptions are
transparent, being systematically detailed in the Additional
file 1, supported by local expert opinion and literature from
the region and included in the sensitivity analysis.
Prevention of diabetes
In Tunisia, the importance of diabetes and its impact
was well recognized early in the 1990s. Organizationally,
national programs for hypertension and diabetes were
developed. These programs are focusing on capacity health
personal training, early detection and treatment and pa-
tient education. Obesity and tobacco control strategies
have been developed [42]. Obesity reduction is focusing on
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bacco control is based on legislation, education at work
sites and schools and the implementation of outpatient
smoking cessation clinics in health centers. These came
together in a 2008–2013 Action Plan on NCD Prevention
and Control. Reducing risk factors or arresting the rise in
disease levels will depend on adopting high-impact mea-
sures at the population level, coupled with active engage-
ment of relevant health sectors. However, it is commonly
acknowledged that there is a gap between the recommen-
dations and practice.
Our results suggest that a population primary preven-
tion strategy would result in a considerable reduction of
the diabetes burden, but it will probably need to be more
ambitious in its targets.
Relatively small improvements in nutrition, reductions
in obesity and smoking and increases in physical activity,
if applied across a whole population, can have a large
impact on the rates of T2D, and other chronic diseases
that share the same risk factors (such as cardiovascular
disease and many cancers). Much more attention needs
to be focused on how to achieve such population-wide
changes. With this in mind, the International Diabetes
Federation (IDF) population strategy requires the govern-
ments of all countries to develop and implement a
National Diabetes Prevention Plan. This national plan
would encompass many groups including schools, com-
munities (for example, religious and ethnic groups), indus-
try (marketing, investment policy, product development)
and the workplace (health promotion within the working
environment) [43].
In Finland, one of the first countries to implement a
national strategy for primary prevention of T2D, the pre-
vention and care of people with T2D are taken very
seriously. The DEHKO project in Finland provides an
example of a comprehensive approach to T2D preven-
tion and management, which aims to improve nutrition
and physical activity across the population, identify and
provide individualized support to those at high risk of
T2D and assist with the early detection and management
of those who are already have T2D [44].
Thus far, the interim evaluation reports of DEHKO show
that the objectives being met, some ahead of schedule. Pre-
ventive action has gained a firm foothold in the primary
care sector, and diabetes education is increasing. The
Finnish government is a model for nations facing the grow-
ing need for diabetes prevention and care, and the Finnish
Diabetes Association, a nongovernmental organization, has
shown creativity and innovation in the delivery of pro-
grams for diabetes in the country [45].
Conclusions
This model provides a reasonably close estimate of dia-
betes prevalence for Tunisia over the 1997–2027 period,compared with an independent prevalence survey in the
same population. Diabetes burden is now a significant
public health challenge, and our model predicts that
its burden will increase significantly in the next two
decades. Tackling obesity and other diabetes risk fac-
tors therefore needs urgent action and a review of the
current national strategy targets [46].
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